Subclass distribution of maternal and neonatal Anti-Ro(SSA) and La(SSB) antibodies in congenital heart block

被引:0
|
作者
Tseng, CE [1 ]
Caldwell, K [1 ]
Feit, S [1 ]
Chan, EKL [1 ]
Buyon, JP [1 ]
机构
[1] SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, WM KECK AUTOIMMUNE DIS CTR, LA JOLLA, CA USA
关键词
anti-Ro(SSA) antibodies; subclass distribution; neonatal lupus; anti-La(SSB) antibodies; congenital heart block;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To compare the subclass distribution of anti-48 kDa La(SSB) and anti-52 and 60 kDa Ro(SSA) antibodies in the maternal and neonatal circulation, in pregnancies affected and unaffected by the development of congenital heart block (CHB). Methods. Sera were obtained from 32 mothers (during 34 pregnancies, 23 complicated by CHB and 11 healthy) demonstrated to have anti-Ro(SSA) and/or La(SSB). Maternal and neonatal autoantibodies were evaluated for subclass distribution by ELISA. Results. All 4 subclasses of anti-Ro(SSA) and La(SSB) antibodies cross the placenta and are detectable in sera obtained from the umbilical cord. IgG1 and IgG3 were the major subclasses represented in the 48 kDa La(SSB) and 52 kDa Ro(SSA) responses. All subclasses, including IgG2 and IgG4, were observed in about one-third of the anti-52 kDa Ro(SSA) and 48 kDaLa(SSB) responses. In contrast, anti-60 kDa antibodies were, with rare exception, confined to IgG1. Except for anti-48 kDa La(SSB) IgG3 antibodies, no significant differences were observed between affected and unaffected pregnancies in the ratio of maternal to neonatal levels of any of the antibody subclasses. Overall, there were no significant differences in the subclass profiles between mothers whose children had heart block and those who did not. Conclusion. The IgG subclasses of anti-48 kDa La(SSB) and anti-52 and 60 kDa Ro(SSA) do not account for the susceptibility of one fetus versus another for the development of CHB. Anti-60 kDa Ro(SSA) antibodies are more restricted in subclass distribution than anti-52 kDa Ro(SSA) or 48 kDa La(SSB) responses.
引用
收藏
页码:925 / 932
页数:8
相关论文
共 50 条
  • [21] NAFTNet retrospective report on the treatment of anti-Ro/SSA mediated fetal heart block with dexamethasone
    Sunderji, Sherzana
    Peyvandi, Shabnam
    Jaeggi, Edgar
    Szwast, Anita
    Ryan, Greg
    Tessier, Francine
    Siddiqui, Saad
    Cuneo, Bettina
    Sheth, Shreya
    Treadwell, Marjorie
    Frommelt, Michele
    Turan, Shifa
    Copel, Joshua
    Emery, Stephen
    Rand, Larry
    Moon-Grady, Anita J.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2022, 35 (25) : 9263 - 9270
  • [22] Pregnancy Outcomes in Patients with Autoimmune Diseases and Anti-Ro/SSA Antibodies
    Antonio Brucato
    Rolando Cimaz
    Roberto Caporali
    Véronique Ramoni
    Jill Buyon
    Clinical Reviews in Allergy & Immunology, 2011, 40 : 27 - 41
  • [23] A New Presentation of Neonatal Lupus: 5 Cases of Isolated Mild Endocardial Fibroelastosis Associated with Maternal Anti-SSA/Ro and Anti-SSB/La Antibodies
    Guettrot-Imbert, Gaelle
    Cohen, Laurence
    Fermont, Laurent
    Villain, Elisabeth
    Frances, Camille
    Thiebaugeorges, Olivier
    Foliguet, Bernard
    Leroux, Gaelle
    Cacoub, Patrice
    Amoura, Zahir
    Piette, Jean-Charles
    Costedoat-Chalumeau, Nathalie
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (02) : 378 - 386
  • [24] Arrhythmogenic effects of anti-Ro/SSA antibodies on the adult heart: More than expected?
    Lazzerini, Pietro Enea
    Capecchi, Pier Leopoldo
    Acampa, Maurizio
    Selvi, Enrico
    Guideri, Francesca
    Bisogno, Stefania
    Rossi, Pier Carlo
    Galeazzi, Mauro
    Pasini, Franco Laghi
    AUTOIMMUNITY REVIEWS, 2009, 9 (01) : 40 - 44
  • [25] Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block
    Skog, Amanda
    Lagnefeldt, Linda
    Conner, Peter
    Wahren-Herlenius, Marie
    Sonesson, Sven-Erik
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2016, 95 (01) : 98 - 105
  • [26] Anti-Ro/SSA autoantibody-positive women's experience of information given on the risk of congenital heart block
    Tingstrom, J.
    Hjelmstedt, A.
    Henriksson, E. Welin
    Ambrosi, A.
    Sonesson, S-E
    Wahren-Herlenius, M.
    LUPUS, 2016, 25 (05) : 536 - 542
  • [27] Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy
    Miyasato-Isoda, Mai
    Waguri, Masako
    Yamada, Yuko
    Miyano, Akira
    Wada, Yoshinao
    MODERN RHEUMATOLOGY, 2018, 28 (04) : 690 - 696
  • [28] Patterns of endocardial fibroelastosis without atrioventricular block in fetuses exposed to anti-Ro/SSA antibodies
    Keller, S. B.
    Cohen, J.
    Moon-Grady, A.
    Cuneo, B.
    Paul, E.
    Coll, A. C.
    Campbell, M.
    Srivastava, S.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2023, 62 (01) : 148 - 151
  • [29] Recurrent Congenital Heart Block Due to Maternal Anti-Ro Antibodies: Successful Prevention of Poor Pregnancy Outcome with Hydroxychloroquine and Added Dexamethasone
    Cimpoca-Raptis, Brindusa
    Ciobanu, Anca Marina
    Gica, Nicolae
    Scutelnicu, Ana Maria
    Bouariu, Alexandra
    Popescu, Mihaela
    Panaitescu, Anca Maria
    REPRODUCTIVE MEDICINE, 2022, 3 (01): : 36 - 41
  • [30] Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the "Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group"
    Scarsi, M.
    Radice, A.
    Pregnolato, F.
    Ramoni, V.
    Grava, C.
    Bianchi, L.
    Gerosa, M.
    Mosca, M.
    Ghirardello, A.
    Tani, C.
    Motta, M.
    Quinzanini, M.
    Tincani, A.
    Ruffatti, A.
    Migliorini, P.
    Doria, A.
    Meroni, P. L.
    Brucato, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (06) : 848 - 854